Study provides clearer picture of cancer risk

January 27, 2014 by Sarah Lyn Cobleigh Keblin

(Medical Xpress)—A University of Vermont researcher has helped to develop a more accurate way of studying genetic changes to identify people at high risk for colon and other cancers. The findings are published in Nature Genetics.

Marc Greenblatt, M.D., an associate professor of medicine and oncologist at the University of Vermont (UVM) and Fletcher Allen Health Care, and faculty member at the Vermont Cancer Center's Familial Cancer Program, co-led a collaborative global effort to interpret genetic data related to hereditary colon cancer. The team's findings will both allow doctors to access publicly-available data to more effectively interpret risks and give patients a more accurate picture of familial risk for colon and other cancers.

The identification of a high-risk mutation in a cancer patient guides the clinical management of that patient and their family, including considerations for counselling, treatment options, surgery and other risk-reducing interventions. Lynch Syndrome is an inherited condition that greatly increases the risk for colon, uterine and other cancers. It is responsible for three to five percent of all colon cancers. For patients who are suspected of genetic variations that cause Lynch Syndrome, genetic test results have been difficult to interpret, therefore limiting the ability of these patients and their families to manage cancer risks.

Greenblatt and his international collaborators focused on in four genes that are responsible for Lynch Syndrome. Genetic testing to look for harmful mutations is frequently done. However, when genetic changes are found, about one quarter of them are difficult to interpret. Individuals presenting with these genetic variations have traditionally been told they have "variants of uncertain significance" – the results are inconclusive and cannot be used to help guide patient care or predict risk for family members.

The team of researchers, working through the International Society for Gastrointestinal Hereditary Cancers (InSiGHT), pooled the knowledge and collective data of more than 45 researchers and clinicians across the world, each with a specific type of expertise in the area of Lynch Syndrome. Together, they developed a new model of classifying , "in many cases turning indecipherable sequencing data into real knowledge that can have a clinical benefit," says Greenblatt.

"As a result of this work," he adds, "doctors can more conclusively say whether those patients have Lynch Syndrome, and focus prevention efforts on the family members who are at a high risk of getting . We may also ease the worry of some people who've had inconclusive results that turn out not to be dangerous. This team approach can also serve as a model for research efforts in the future on other genetic conditions."

Explore further: New genetic screening test for Lynch Syndrome

More information: "Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database." Bryony A Thompson, Amanda B Spurdle, John-Paul Plazzer, Marc S Greenblatt, Kiwamu Akagi, et al. Nature Genetics (2013) DOI: 10.1038/ng.2854. Received 19 September 2013 Accepted 26 November 2013 Published online 22 December 2013

Related Stories

New genetic screening test for Lynch Syndrome

December 24, 2013
People at high risk of cancer of the bowel and womb due to a genetic condition will receive a more accurate diagnosis as a result of a new model developed by a team of international scientists.

Study allows better prediction of the risk of hereditary cancer

January 15, 2014
An international study has developed a refined method to identify people at risk for certain inherited cancer as a result of Lynch syndrome.

Evidence mounts for endometrial cancer tumor testing to identify women with Lynch syndrome

December 11, 2013
A recent article by Norris Cotton Cancer Center researchers published in the January 2014 issue of the journal Clinical Chemistry reviews the scientific evidence that warrants screening all endometrial cancers for Lynch syndrome. ...

Researchers develop clinical screening program for no.1 genetic cause of colon cancer

February 14, 2013
(Medical Xpress)—Cleveland Clinic researchers have found that colorectal cancer outcomes could be improved with regular genetic screening for Lynch syndrome, the most common hereditary, adult-onset cause of colorectal cancer, ...

Study revises colorectal cancer risk down and other cancer risks up for women with Lynch Syndrome

February 26, 2013
Lynch Syndrome is a heritable genetic mutation that causes colorectal, endometrial and other cancers. A cooperative study that included the University of Colorado Cancer Center, published in this month's issue of the Journal ...

New Mayo Clinic test targets Lynch syndrome, a risk factor for colon cancer

May 18, 2011
Mayo Clinic has developed a screening procedure that could dramatically increase testing for Lynch syndrome, a hereditary genetic disorder that raises cancer risk, particularly for colorectal cancer. An estimated 3 percent ...

Recommended for you

Stem cell therapy attacks cancer by targeting unique tissue stiffness

July 26, 2017
A stem cell-based method created by University of California, Irvine scientists can selectively target and kill cancerous tissue while preventing some of the toxic side effects of chemotherapy by treating the disease in a ...

Understanding cell segregation mechanisms that help prevent cancer spread

July 26, 2017
Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.

Study uncovers potential 'silver bullet' for preventing and treating colon cancer

July 26, 2017
In preclinical experiments, researchers at VCU Massey Cancer Center have uncovered a new way in which colon cancer develops, as well as a potential "silver bullet" for preventing and treating it. The findings may extend to ...

Compound shows promise in treating melanoma

July 26, 2017
While past attempts to treat melanoma failed to meet expectations, an international team of researchers are hopeful that a compound they tested on both mice and on human cells in a petri dish takes a positive step toward ...

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.